PHOGEN LTD has a total of 31 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are TAIGA BIOTECHNOLOGIES INC, GENESIS RES AND DEVELOPMENT CORPORATION LIMITED and LEXICON GENETICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Australia | 6 | |
#3 | Canada | 5 | |
#4 | Mexico | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | EPO (European Patent Office) | 3 | |
#7 | United Kingdom | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | O'Hare Peter Francis Joseph | 23 |
#2 | Normand Nadia Michelle | 15 |
#3 | Brewis Neil Douglas | 12 |
#4 | Elliott Gillian Daphne | 7 |
#5 | Phelan Anne | 6 |
#6 | Sunassee Kavitha Renga | 6 |
#7 | Elliot Gillian Daphne | 2 |
#8 | Brewis Neil D | 1 |
#9 | Sunassee Kavitha R | 1 |
#10 | O'Hare Peter Francis | 1 |
Publication | Filing date | Title |
---|---|---|
GB0321311D0 | Delivery of substances to cells | |
AU8731401A | VP22 proteins and uses thereof | |
US6734167B2 | Uses of transport proteins | |
GB0022101D0 | Delivery of substances to cells | |
US6342229B2 | Herpesvirus particles comprising fusion protein and their preparation and use | |
AU6739398A | Vp22 proteins and uses thereof |